A detailed history of Pacer Advisors, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 786 shares of MDXG stock, worth $4,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
786
Previous 1,344 41.52%
Holding current value
$4,495
Previous $10,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.16 - $8.08 $3,437 - $4,508
-558 Reduced 41.52%
786 $5,000
Q1 2024

May 10, 2024

BUY
$7.61 - $8.63 $10,227 - $11,598
1,344 New
1,344 $10,000
Q4 2018

Feb 13, 2019

SELL
$1.15 - $6.45 $55,278 - $310,038
-48,068 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $130,303 - $256,156
40,467 Added 532.39%
48,068 $297,000
Q2 2018

Aug 14, 2018

BUY
$5.39 - $8.96 $25,354 - $42,147
4,704 Added 162.37%
7,601 $49,000
Q1 2018

May 14, 2018

SELL
$6.69 - $17.96 $5,037 - $13,523
-753 Reduced 20.63%
2,897 $20,000
Q4 2017

Feb 14, 2018

BUY
$10.87 - $13.9 $39,675 - $50,735
3,650
3,650 $46,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $650M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.